NuvOx Pharma
NuvOx Pharma is a biotechnology company based in Tucson, Arizona that is developing a first-in-class oxygen therapeutic to treat life-threatening diseases where hypoxia plays a role.
Launch date
Employees
Market cap
-
Enterprise valuation
€27m (Public information from Jun 2023)
Tucson Arizona (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $765k | Seed | |
$200k | Grant | ||
N/A | N/A | Grant | |
N/A | $1.0m | Grant | |
N/A | $500k | Seed | |
N/A | $225k | Grant | |
N/A | $298k | Grant | |
$300k | Grant | ||
N/A | $318k | Grant | |
N/A | $3.0m | Grant | |
N/A | $6.0m | Series A | |
$2.0m | Grant | ||
* | $14.0m | Debt | |
* | $200k Valuation: $30.0m | Early VC | |
Total Funding | €13.5m |
Recent News about NuvOx Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.